Response to COVID-19 vaccines varies widely in blood cancer patients

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines--in some cases, no detectable response--pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study published in Cancer Cell in June.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news